Sun Pharmaceutical Industries Inc recalls
24 recalls filed under Sun Pharmaceutical Industries Inc. The most recent was published October 14, 2026.
-
Class III · 11 days ago
Sun Pharmaceutical Industries Inc Tretinoin Cream USP, 0.05%, 45g tube recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class III · 11 days ago
Sun Pharmaceutical Industries Inc Tretinoin Cream UPS, 0.05%, 20g recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class III · 11 days ago
Sun Pharmaceutical Industries Inc Tretinoin Cream USP, 0.05%, 45 g tube recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class II · 2 months ago
Sun Pharmaceutical Industries Inc Carbamazepine Tablets, USP, 200mg recall: CGMP Deviations; black spots found on tablets from burnt excipient during
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
-
Class III · 4 months ago
Sun Pharmaceutical Industries Inc Fexofenadine Hydrochloride Tablets recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class II · 4 months ago
Sun Pharmaceutical Industries Inc Perampanel CIII Tablets, 6mg recall: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
-
Class I · 4 months ago
Sun Pharmaceutical Industries Inc DOXOrubin Hydrochloride Liposome injection recall: Presence of Particulate matter: Particulate matter identified as glass
Presence of Particulate matter: Particulate matter identified as glass.
-
Class II · 4 months ago
Sun Pharmaceutical Industries Inc Budesonide Inhalation Suspension, 1mg/2mL recall: Presence of Foreign Substance:This recall has been initiated in response
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles…
-
Class II · 5 months ago
Sun Pharmaceutical Industries Inc Xyvona , 3mg, 100 Tablets recall: Labeling: Not Elsewhere Classified. This recall has been initiated
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary…
-
Class II · 5 months ago
Sun Pharmaceutical Industries Inc Xyvona , 2mg, 100 Tablets recall: Labeling: Not Elsewhere Classified. This recall has been initiated
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary…
-
Class II · 6 months ago
Sun Pharmaceutical Industries Inc Fluocinonide, USP, 0.05% Cream, 15g tube recall: Failed Viscosity Specifications: Out of Specification results
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class II · 6 months ago
Sun Pharmaceutical Industries Inc Fluocinonide, USP, 0.05% Cream, 60g tube recall: Failed Viscosity Specifications: Out of Specification results
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class II · 6 months ago
Sun Pharmaceutical Industries Inc Fluocinonide, USP, 0.05% Cream, 30g tube recall: Failed Viscosity Specifications: Out of Specification results
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
-
Class II · 9 months ago
Sun Pharmaceutical Industries Inc Diclofenac Sodium, Topical Gel, 3%, 100 g tube recall: Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
-
Class III · 9 months ago
Sun Pharmaceutical Industries Inc Clindamycin Phosphate USP, 1% , Topical Solution recall: Failed Impurities/Degradation: Out of Specification results for Total
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
-
Class III · 9 months ago
Sun Pharmaceutical Industries Inc Fluocinolone Acetonide Solution Topical Solution recall: Failed Impurities/Degradation Specifications: Out of specification result
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 30 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 40 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 10 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 20 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 70 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 50 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 60 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 1+ years ago
Sun Pharmaceutical Industries Inc Kit for the Preparation of Technetium Tc 99m recall: Failed Dissolution Specifications-Out of Specification (OOS) observation
Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of…
About this page
Sun Pharmaceutical Industries Inc appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.